Advanced Medical Solutions sets AGM for June 30, adjusts dividend date

Published 14/05/2025, 15:08
Advanced Medical Solutions sets AGM for June 30, adjusts dividend date

WINSFORD, UK - Advanced Medical (TASE:BLWV) Solutions Group plc (AIM:AMS (VIE:AMS2)), a leader in tissue-healing technologies, has announced a rescheduling of its Annual General Meeting (AGM) to June 30, 2025. The change comes after an unexpected alteration in the audit team at Deloitte LLP, which has delayed the signing of the Annual Report and Accounts.

In connection with this scheduling update, the company has also modified the record date for its proposed final dividend. Shareholders on the register at the close of business on June 20, 2025, will be eligible for the dividend, subject to shareholder approval at the AGM. This dividend, set at 1.83p per share, is slated for distribution on July 17, 2025.

The initial announcement of the company’s FY24 Unaudited Preliminary Results was made on March 19, 2025, under RNS 2726B. This recent adjustment to the dividend record date aligns with the new AGM schedule, ensuring compliance with corporate governance requirements and providing clarity to shareholders.

Advanced Medical Solutions Group is recognized for its comprehensive portfolio of surgical products, including tissue adhesives, sutures, haemostats, and fixation devices, which are marketed under various brands such as LiquiBand®, RESORBA®, and Seal-G®. The company also offers wound care dressings through its ActivHeal® brand, in addition to products available under white label.

With a global presence, AMS products are manufactured across several countries and sold through a combination of multinational and regional partners, as well as direct sales forces in select markets. The Group is committed to research and development, with innovation hubs located in the UK, Ireland, Germany, France, and Israel.

This information is based on a press release statement issued by Advanced Medical Solutions Group plc.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.